Biodegradable gelatin microparticles as delivery systems for the controlled release of bone morphogenetic protein-2.
暂无分享,去创建一个
Antonios G Mikos | Yasuhiko Tabata | A. Mikos | Y. Tabata | Masaya Yamamoto | H. Ueda | Masaya Yamamoto | Zarana S. Patel | Zarana S Patel | Hiroki Ueda
[1] J. Lane,et al. Current understanding of osteoconduction in bone regeneration. , 1998, Clinical orthopaedics and related research.
[2] David L. Kaplan,et al. BMP-silk composite matrices heal critically sized femoral defects. , 2007, Bone.
[3] Antonios G Mikos,et al. In vitro degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds. , 2005, Biomaterials.
[4] K E Healy,et al. Ectopic bone formation via rhBMP-2 delivery from porous bioabsorbable polymer scaffolds. , 1998, Journal of biomedical materials research.
[5] Antonios G Mikos,et al. In vitro release of transforming growth factor-beta 1 from gelatin microparticles encapsulated in biodegradable, injectable oligo(poly(ethylene glycol) fumarate) hydrogels. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[6] P. Deluca,et al. Porous bone morphogenetic protein-2 microspheres: Polymer binding and in vitro release , 2001, AAPS PharmSciTech.
[7] S. Chueh,et al. Collagen-hydroxyapatite microspheres as carriers for bone morphogenic protein-4. , 2003, Artificial organs.
[8] P. Deluca,et al. Effect of a freeze-dried CMC/PLGA microsphere matrix of rhBMP-2 on bone healing , 2001, AAPS PharmSciTech.
[9] Y. Tabata,et al. Repairing of rabbit skull defect by dehydrothermally crosslinked collagen sponges incorporating transforming growth factor beta1. , 2003, Journal of controlled release : official journal of the Controlled Release Society.
[10] Y. Ikada,et al. Controlled release of growth factors based on biodegradation of gelatin hydrogel , 2001, Journal of biomaterials science. Polymer edition.
[11] R. Mehta,et al. Interaction of recombinant human bone morphogenetic protein-2 with poly(d,l lactide-co-glycolide) microspheres. , 1996, Pharmaceutical development and technology.
[12] K. Takaoka,et al. Repair of a proximal femoral bone defect in dogs using a porous surfaced prosthesis in combination with recombinant BMP-2 and a synthetic polymer carrier. , 2003, Biomaterials.
[13] G. Lewis. Alternative acrylic bone cement formulations for cemented arthroplasties: present status, key issues, and future prospects. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.
[14] Antonios G Mikos,et al. Transforming growth factor-beta 1 release from oligo(poly(ethylene glycol) fumarate) hydrogels in conditions that model the cartilage wound healing environment. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[15] K. An,et al. Mechanical properties of a biodegradable bone regeneration scaffold. , 2000, Journal of biomechanical engineering.
[16] Antonios G Mikos,et al. rhBMP-2 Release from Injectable Poly(DL-Lactic-co-glycolic Acid)/Calcium-Phosphate Cement Composites , 2003, The Journal of bone and joint surgery. American volume.
[17] Kazutoshi Nozaki,et al. A biodegradable polymer as a cytokine delivery system for inducing bone formation , 2001, Nature Biotechnology.
[18] J. Jansen,et al. Effect of varied release kinetics of the osteogenic thrombin peptide TP508 from biodegradable, polymeric scaffolds on bone formation in vivo. , 2005, Journal of biomedical materials research. Part A.
[19] W. Parks. Matrix metalloproteinases in repair , 1999, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.
[20] J. Jansen,et al. In vivo degradation of porous poly(propylene fumarate)/poly(DL-lactic-co-glycolic acid) composite scaffolds. , 2005, Biomaterials.
[21] Antonios G Mikos,et al. Gelatin as a delivery vehicle for the controlled release of bioactive molecules. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[22] H. Burchardt. The biology of bone graft repair. , 1983, Clinical orthopaedics and related research.
[23] W. Friess,et al. Collagen sponges for bone regeneration with rhBMP-2. , 2003, Advanced drug delivery reviews.
[24] K. Ishihara,et al. Bone morphogenetic protein encapsulated with a biodegradable and biocompatible polymer. , 1996, Journal of biomedical materials research.
[25] K E Healy,et al. Engineering bone regeneration with bioabsorbable scaffolds with novel microarchitecture. , 1999, Tissue engineering.
[26] A. Mikos,et al. Crosslinking characteristics of and cell adhesion to an injectable poly(propylene fumarate-co-ethylene glycol) hydrogel using a water-soluble crosslinking system. , 2003, Tissue engineering.
[27] M. Bostrom,et al. Expression of bone morphogenetic proteins in fracture healing. , 1998, Clinical orthopaedics and related research.
[28] Y. Ikada,et al. Biodegradation of hydrogel carrier incorporating fibroblast growth factor. , 1999, Tissue engineering.
[29] J. Hassell,et al. Extracellular matrix : a practical approach , 1995 .
[30] J. Fisher,et al. Soft and hard tissue response to photocrosslinked poly(propylene fumarate) scaffolds in a rabbit model. , 2002, Journal of biomedical materials research.
[31] M Kellomäki,et al. Bioabsorbable scaffolds for guided bone regeneration and generation. , 2000, Biomaterials.
[32] Antonios G. Mikos,et al. In Vitro and In Vivo Release of Vascular Endothelial Growth Factor from Gelatin Microparticles and Biodegradable Composite Scaffolds , 2008, Pharmaceutical Research.
[33] Zarana S. Patel. Controlled delivery of angiogenic and osteogenic growth factors for bone regeneration , 2008 .
[34] Ikada,et al. Protein release from gelatin matrices. , 1998, Advanced drug delivery reviews.
[35] M. Kohno,et al. Distribution and Characterization of Specific Cellular Binding Proteins for Bone Morphogenetic Protein-2 (*) , 1995, The Journal of Biological Chemistry.
[36] F. Greenwood,et al. THE PREPARATION OF I-131-LABELLED HUMAN GROWTH HORMONE OF HIGH SPECIFIC RADIOACTIVITY. , 1963, The Biochemical journal.
[37] Y. Tabata,et al. Controlled release by biodegradable hydrogels enhances the ectopic bone formation of bone morphogenetic protein. , 2003, Biomaterials.
[38] Antonios G Mikos,et al. Dual growth factor delivery from degradable oligo(poly(ethylene glycol) fumarate) hydrogel scaffolds for cartilage tissue engineering. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[39] M. Wiemann,et al. The Binding of rhBMP‐2 to the Receptors of viable MC3T3‐E1 Cells and the Question of Cooperativity , 2001 .
[40] J A Schrier,et al. Recombinant human bone morphogenetic protein-2 binding and incorporation in PLGA microsphere delivery systems. , 1999, Pharmaceutical development and technology.
[41] D J Mooney,et al. Development of biocompatible synthetic extracellular matrices for tissue engineering. , 1998, Trends in biotechnology.
[42] J. Wozney,et al. rhBMP‐Collagen Sponges as Osteoinductive Devices: Effects of in Vitro Sponge Characteristics and Protein pI on in Vivo rhBMP Pharmacokinetics , 1999, Annals of the New York Academy of Sciences.
[43] N. Lang,et al. Effect of bioresorbable fibres (Polyfibre) and a bioresorbable foam (Polyfoam) on new bone formation. A short term experimental study on the rabbit skull. , 2003, Clinical oral implants research.
[44] W. Hunter,et al. The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent. , 1973, The Biochemical journal.
[45] Thomas A Einhorn,et al. Fracture healing as a post‐natal developmental process: Molecular, spatial, and temporal aspects of its regulation , 2003, Journal of cellular biochemistry.